RIGL Markets Signal, Research & Overview

Timing · 1D

Technicals

SummaryData pending

OscillatorsData pending

Moving averagesData pending

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 4, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$681.06M

Trailing Pe1.91

Growth and income

Eps19.29

Free Cash Flow$78.55M

Net Income$8.65M

Profitability

Ebitda$126.99M

Gross Profit$54.21M

Balance sheet

Free Cash Flow$78.55M

Total Assets$504.61M

Total Liabilities$104.71M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

AMGNAmgen Inc+0.00%Market co-movement · Residual co-movement · Directional relationship ACADACADIA PHARMACEUTICALS INC+0.00%Market co-movement · Residual co-movement LMNDLEMONADE INC+0.00%Market co-movement · Residual co-movement VCYTVERACYTE INC+0.00%Market co-movement · Residual co-movement SRPTSAREPTA THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement · Directional relationship

RelationshipsLoading

RIGEL PHARMACEUTICALS INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships